Atomfair DL-alpha-Methylleucine C7H15NO2

Description DL-alpha-Methylleucine (CAS No. 29589-03-5) is a high-purity, non-proteinogenic amino acid with the molecular formula C7H15NO2. This racemic compound, systematically named 2-amino-2,4-dimethylpentanoic acid , features a unique branched-chain structure with two methyl groups at the alpha and gamma positions, making it a valuable building block for peptide modification and biochemical research. Offered as a white crystalline powder with ??98% purity (HPLC), it is soluble in water and polar organic solvents. Ideal for proteomics, enzyme inhibition studies, and medicinal chemistry applications, this product is rigorously tested for identity (FTIR/NMR), heavy metals (

Description

Description

DL-alpha-Methylleucine (CAS No. 29589-03-5) is a high-purity, non-proteinogenic amino acid with the molecular formula C7H15NO2. This racemic compound, systematically named 2-amino-2,4-dimethylpentanoic acid, features a unique branched-chain structure with two methyl groups at the alpha and gamma positions, making it a valuable building block for peptide modification and biochemical research. Offered as a white crystalline powder with ??98% purity (HPLC), it is soluble in water and polar organic solvents. Ideal for proteomics, enzyme inhibition studies, and medicinal chemistry applications, this product is rigorously tested for identity (FTIR/NMR), heavy metals (<10 ppm), and residual solvents to meet stringent research standards. Each batch includes comprehensive analytical documentation (CoA, MSDS) for traceability and regulatory compliance.

  • CAS No: 29589-03-5
  • Molecular Formula: C7H15NO2
  • Molecular Weight: 145.20
  • Exact Mass: 145.110278721
  • Monoisotopic Mass: 145.110278721
  • IUPAC Name: 2-amino-2,4-dimethylpentanoic acid
  • SMILES: CC(C)CC(C)(C(=O)O)N
  • Synonyms: DL-alpha-Methylleucine, 144-24-1, 2-amino-2,4-dimethylpentanoic acid, H-alpha-Me-DL-Leu-OH, T2MJ2EEP1K

Application

DL-alpha-Methylleucine serves as a critical chiral auxiliary in asymmetric synthesis and peptidomimetic drug development, where its sterically hindered structure induces conformational constraints in synthetic peptides. Researchers utilize this compound to investigate branched-chain amino acid metabolism disorders and as a precursor for novel enzyme inhibitors targeting leucine-processing pathways. Its non-natural configuration makes it particularly valuable for studying substrate specificity in aminoacyl-tRNA synthetases and developing antibiotic resistance breakers.

If you are interested or have any questions, please contact us at support@atomfair.com